Tachykinins and the potential causal factors for post-COVID-19 condition
The most prevalent symptoms of post-COVID-19 condition are pulmonary dysfunction,
fatigue and muscle weakness, anxiety, anosmia, dysgeusia, headaches, difficulty in …
fatigue and muscle weakness, anxiety, anosmia, dysgeusia, headaches, difficulty in …
[HTML][HTML] Substance P/Neurokinin-1 receptor, trigeminal ganglion, latency, and coronavirus infection-is there any link?
Novel Severe Acute Respiratory Syndrome-Corona Virus-2 infection (SARS-CoV-2) is an
acute respiratory and infectious disease. This perspective aims to provide a basic …
acute respiratory and infectious disease. This perspective aims to provide a basic …
[PDF][PDF] Kinins and cytokines in COVID-19: a comprehensive pathophysiological approach
F van de Veerdonk, MG Netea, M van Deuren… - 2020 - pdfs.semanticscholar.org
Most striking observations in COVID-19 patients are the hints on pulmonary edema (also
seen on CT scans as ground glass opacities), dry cough, fluid restrictions to prevent more …
seen on CT scans as ground glass opacities), dry cough, fluid restrictions to prevent more …
Between two storms, vasoactive peptides or bradykinin underlie severity of COVID‐19?
VT Karamyan - Physiological Reports, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to be a world‐wide pandemic with …
syndrome coronavirus 2 (SARS‐CoV‐2), continues to be a world‐wide pandemic with …
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases
Bradykinin, a member of the kallikrein–kinin system (KKS), is a potent, short-lived vasoactive
peptide that acts as a vasodilator and an inflammatory mediator in a number of signaling …
peptide that acts as a vasodilator and an inflammatory mediator in a number of signaling …
Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID‐19?
AS Gouda, B Mégarbane - Drug Development Research, 2021 - Wiley Online Library
The severe acute respiratory syndrome coronavirus‐2 (SARS‐COV‐2), a novel coronavirus
responsible for the recent infectious pandemic, is known to downregulate angiotensin …
responsible for the recent infectious pandemic, is known to downregulate angiotensin …
Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID‐19
The COVID‐19 pandemic is rapidly spreading, and health care systems are being
overwhelmed with the huge number of cases, with a good number of cases requiring …
overwhelmed with the huge number of cases, with a good number of cases requiring …
Safety and outcomes associated with the pharmacological inhibition of the kinin–kallikrein system in severe COVID-19
E Mansour, AC Palma, RG Ulaf, LC Ribeiro… - Viruses, 2021 - mdpi.com
Background: Coronavirus disease 19 (COVID-19) can develop into a severe respiratory
syndrome that results in up to 40% mortality. Acute lung inflammatory edema is a major …
syndrome that results in up to 40% mortality. Acute lung inflammatory edema is a major …
Bradykinin as a probable aspect in SARS-Cov-2 scenarios: is bradykinin sneaking out of our sight?
The new virus SARS-CoV-2 is savagely spreading out over the world. The biologic studies
show that the target receptor for the virus might be angiotensin-converting enzyme 2 (ACE2) …
show that the target receptor for the virus might be angiotensin-converting enzyme 2 (ACE2) …
[HTML][HTML] Neurokinin-1 receptor as a potential drug target for COVID-19 treatment
R Mehboob - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract Novel Coronavirus infection (COVID-19) has become a pandemic in these days. It
is an acute respiratory and infectious disease with no known etiology and treatment. It is …
is an acute respiratory and infectious disease with no known etiology and treatment. It is …